FIFARMA is the Latin American Federation of the Pharmaceutical Industry created in 1962. We represent 14 research-based biopharmaceutical companies and 11 local associations dedicated to discovering and developing innovative, quality and safe health products and services that improve the lives of patients in Latin America and the Caribbean and advocate for patient-centric, sustainable health systems characterized by high regulatory standards and ethical principles.
Who We Are
What We Do
We bring the Latin American & Caribbean research & development (R&D) biopharmaceutical industry and the health community together to shape health policies that prolong, preserve and improve life for patients.
How We Work
We promote dialogue within our industry and in close collaboration with intergovernmental bodies, non-governmental organizations, health authorities and civil society organizations to bring value to society by advocating for sustainable health systems with high regulatory standards and ethical principles and offering longer and better lives to patients.
FAIRNESS: Integrity and accountability are the foundations of our work.
HONESTY: We champion ethics and transparency across the healthcare industry in Latin America.
RESPECT: We believe that respect for ourselves, our members, partners and stakeholders
is paramount to achieving our mission.
CARE: We aim to improve patient care and public health by promoting innovation and quality.
We share the same values with our global pharmaceutical industry association, the International
Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
Our Leadership & Staff
FIFARMA is led by an Executive Committee composed of senior executives from the leading biopharmaceutical Companies and Local Associations in Latin America & Caribbean.
The Executive Committee is guided by a Steering Committee comprising the Chair and Co-chair, as well as the Local Association’s Chair and FIFARMA Executive Director.
FIFARMA staff works closely with the Steering and Executive Committee as well as with members to prioritize strategic areas of focus where close collaboration and dialogue between private and public healthcare stakeholders is facilitated.
The success of FIFARMA and our members is directly connected to how we conduct our business every day. For that reason, we adhere to the International Federation of Pharmaceutical Manufacturers & Associations’ (IFPMA) strict ethical guidelines in our daily work and promote the importance of ethical business practices across our members and the industry through different initiatives.
FIFARMA represents 14 biopharmaceutical companies and 11 local industry associations in Latin America and the Caribbean.